Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,289 public trials 2,070 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives

NCT03084133

Conditions
Cancer Colorectal, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • Service d'Hépatogastro-entérologie CHU ANGERS Angers, France
  • Service d'Hépatogastro-entérologie CHG BLOIS Blois, France
  • Service d'Hépatogastro-entérologie CHG de DREUX Dreux, France
  • Service de Médecine CHG de Loches Loches, France
View Trial Details
Completed

A Study in Second Line Metastatic Colorectal Cancer

NCT01183780

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sedona, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
View all 213 locations
View Trial Details
Completed

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

NCT00917384

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations
  • ImClone Investigational Site Bakersfield, California, United States
  • ImClone Investigational Site La Jolla, California, United States
  • ImClone Investigational Site Redlands, California, United States
  • ImClone Investigational Site Chicago, Illinois, United States
View all 161 locations
View Trial Details
Completed

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists-South Fort Myers, Florida, United States
  • Woodlands Medical Specialists Pensacola, Florida, United States
  • Florida Cancer Specialists-North St. Petersburg, Florida, United States
View Trial Details
Completed

NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome

NCT02570516

Conditions
Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +15 more
Locations
  • HCL - Hôpital Edouard-Herriot Lyon, Auvergne-Rhône-Alpes, France
  • CHRU de Tours - Hôpital Trousseau Chambray-lès-Tours, Centre-Val de Loire, France
  • CHU Nantes - Hôtel-Dieu Nantes, Pays de la Loire Region, France
  • AP-HP - Hôpital Européen Georges-Pompidou Paris, France
View Trial Details

Related conditions